Therapeutic Asset Ratings

435 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
(+)-VINCRISTINE High Grade B-Cell Lymphoma	OHSU Knight Cancer Institute	P3	BB (64)
Arimidex Ovarian Carcinoma	OHSU Knight Cancer Institute	P2	BB (64)
Carboplatin Prostate Carcinoma	OHSU Knight Cancer Institute	P2	BB (64)
Epirubicin Recurrent Acute Lymphoblastic Leukemia	OHSU Knight Cancer Institute	P2	BB (64)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive	OHSU Knight Cancer Institute	P2	BB (64)
Inno-206 Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive	OHSU Knight Cancer Institute	P2	BB (64)
Olaparib Non-Hodgkin Lymphoma	OHSU Knight Cancer Institute	P2	BB (64)
Olaparib Prostate Carcinoma	OHSU Knight Cancer Institute	P2	BB (64)
Olaparib Soft Tissue Sarcoma	OHSU Knight Cancer Institute	P2	BB (64)
Olaparib Refractory Non-Hodgkin Lymphoma	OHSU Knight Cancer Institute	P2	BB (64)
PREDNISONE TABLETS Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive	OHSU Knight Cancer Institute	P2	BB (64)
Vinorelbine Ovarian Carcinoma	OHSU Knight Cancer Institute	P2	BB (64)
Cladribine Acute Monocytic Leukemia	OHSU Knight Cancer Institute	P2/3	BB (64)
Capecitabine Recurrent Ovarian Carcinoma	OHSU Knight Cancer Institute	P3	B (63)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Anemia	OHSU Knight Cancer Institute	P3	B (63)
Irinotecan Sarcoma	OHSU Knight Cancer Institute	P3	B (63)
Alpelisib Breast Carcinoma	OHSU Knight Cancer Institute	P2	B (63)
Carboplatin Advanced Malignant Solid Neoplasm	OHSU Knight Cancer Institute	P2	B (63)
Cyclophosphamide Prostate Carcinoma	OHSU Knight Cancer Institute	P2	B (63)
Dasatinib Pancreatic Adenocarcinoma	OHSU Knight Cancer Institute	P2	B (63)
Epirubicin Recurrent Prostate Carcinoma	OHSU Knight Cancer Institute	P2	B (63)
Gdc-0449 Breast Carcinoma	OHSU Knight Cancer Institute	P2	B (63)
Gdc-0449 Breast Cancer	OHSU Knight Cancer Institute	P2	B (63)
Gdc-0449 Recurrent Breast Carcinoma	OHSU Knight Cancer Institute	P2	B (63)
Inno-206 Metastatic Pancreatic Adenocarcinoma	OHSU Knight Cancer Institute	P2	B (63)

Showing 51 to 75 of 435 assets

PreviousPage 3 of 18Next